Scientists develop spectroscopy-based COVID-19 triage tool

By staff writers

August 19, 2021 -- Attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy is a rapid, low-cost tool that can be used to triage the severity of illness in patients with COVID-19, according to research published recently in Analytical Chemistry.

Indian and Australian researchers collected infrared spectra of blood plasma from 160 COVID-positive patients from Mumbai (130 as a training set for model development and 30 as a blind test set for model validation). They established a simple plasma processing and ATR-FTIR data acquisition procedure using 75% ethanol for viral inactivation.

"We found there were measurable differences in the infrared spectra in the patients who became severely unwell," said Michelle Hill, PhD, of QIMR Berghofer Medical Research Institute in Queensland, in a news release.

Addition of the ATR-FTIR spectra to clinical parameters (age, sex, diabetes mellitus, and hypertension) increased the area under the receiver operating curve (ROC) for both the training and test datasets, from 69.3% to 85.7% in the training set and from 77.8% 85.1% in the blind test set, the researchers found.

Agilent Technologies, which made the Cary 630 FTIR spectrometer used in the study, said the work highlights the potential of ATR-FTIR spectroscopy for COVID-19 and infectious disease research and that the company will continue to support research in the field.

Low-cost COVID-19 test delivers results within 4 minutes
Researchers from the University of Pennsylvania School of Medicine have developed a low-cost, rapid diagnostic test for COVID-19, according to a May 6...
Terahertz spectroscopy opens options in COVID-19 screening
While terahertz spectroscopy has found some niche uses in research it has yet to find its "killer app." It's possible that it may find one in detecting...
Diagnostics wanted for emerging infections, tomorrow's pandemics
While the severity of COVID-19 and its rapid spread was not something anyone anticipated prior to its manifestation in Wuhan, China, last year, the coming...
Sequencing seeks to stay ahead of new COVID-19 surges
While polymerase chain reaction technology has been at the forefront of diagnostics during the COVID-19 pandemic, sequencing has been at the forefront...
Industry roundup: Oncology dominates noncoronavirus IVD news
There's no doubt that COVID-19 tests remain a focal point for IVD research and development. But companies increasingly are announcing new non-COVID-19...

Copyright © 2021

Last Updated ls 8/19/2021 2:58:55 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current